MarketWatch Automation
Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP +9.69% took a -10% dive 10.28% to $0.42 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.73% rising 0.50% to 14,417.55 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 0.63% to 35,629.33. The stock's fall snapped a three-day winning streak. Corbus Pharmaceuticals Holdings Inc. closed $3.58 below its 52-week high ($4.00), which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE -4.50% fell 3.70% to $39.59, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA -2.47% fell 3.62% to $14.66, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX +8.79% fell 6.79% to $3.57. Trading volume (896,100) remained 92,567 below its 50-day average volume of 988,667.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
CRBP
Add to watchlist
DJIA
Add to watchlist
FATE
Add to watchlist
VNDA
Add to watchlist
VKTX
